Karyopharm Therapeutics Inc (KPTI) Insider Trading
- $10,245,912.22
- $142,165,901.96
- Oct. 4, 2024
- Ltd Chione
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 8, 2022 | CEO | 2,115 | $5.18 | Sell | $10,955.70 | |
June 13, 2022 | Insider | 1,551 | $5.21 | Sell | $8,080.71 | |
June 7, 2022 | CEO | 2,542 | $5.76 | Sell | $14,641.92 | |
June 3, 2022 | CFO | 601 | $6.04 | Sell | $3,630.04 | |
Feb. 7, 2022 | Insider | 6,707 | $9.86 | Sell | $66,131.02 | |
Feb. 7, 2022 | CFO | 3,947 | $9.86 | Sell | $38,917.42 | |
Feb. 7, 2022 | Director | 6,764 | $9.86 | Sell | $66,693.04 | |
Feb. 7, 2022 | EVP | 1,704 | $9.86 | Sell | $16,801.44 | |
Dec. 2, 2021 | SVP | 499 | $6.69 | Sell | $3,338.31 | |
May 7, 2021 | EVP | 23,250 | $8.60 | Buy | $199,950.00 | |
May 6, 2021 | Director | 4,000 | $7.82 | Buy | $31,280.00 | |
March 18, 2021 | Insider | 4,000 | $12.39 | Sell | $49,560.00 | |
Feb. 18, 2021 | EVP | 1,186 | $14.83 | Sell | $17,588.38 | |
Feb. 18, 2021 | Insider | 9,495 | $14.83 | Sell | $140,810.85 | |
Dec. 18, 2020 | Director | 5,000 | $18.00 | Sell | $90,000.00 | |
Dec. 7, 2020 | Director | 20,000 | $16.07 | Sell | $321,400.00 | |
Dec. 1, 2020 | EVP | 137,061 | $17.53 | Sell | $2,402,679.33 | |
Oct. 30, 2020 | EVP | 226 | $15.58 | Sell | $3,521.08 | |
Oct. 13, 2020 | EVP | 39,271 | $16.86 | Sell | $662,109.06 | |
Oct. 12, 2020 | CEO | 7,500 | $14.89 | Sell | $111,675.00 | |
Sept. 8, 2020 | EVP | 10,054 | $14.98 | Sell | $150,608.92 | |
Aug. 26, 2020 | Insider | 7,500 | $14.54 | Buy | $109,050.00 | |
Aug. 17, 2020 | CEO | 1,477 | $15.00 | Sell | $22,155.00 | |
July 15, 2020 | CEO | 7,500 | $19.43 | Sell | $145,725.00 | |
July 15, 2020 | EVP | 589 | $19.46 | Sell | $11,461.94 | |
July 10, 2020 | Insider | 15,000 | $19.27 | Sell | $289,050.00 | |
July 9, 2020 | CEO | 7,500 | $19.53 | Sell | $146,475.00 | |
June 15, 2020 | CEO | 7,500 | $16.37 | Sell | $122,775.00 | |
June 10, 2020 | Insider | 15,000 | $16.60 | Sell | $249,000.00 | |
June 9, 2020 | CEO | 7,500 | $18.50 | Sell | $138,750.00 | |
April 8, 2020 | CEO | 10,000 | $18.61 | Sell | $186,100.00 | |
March 9, 2020 | Insider | 10,000 | $22.52 | Sell | $225,200.00 | |
March 2, 2020 | EVP | 26,500 | $25.37 | Sell | $672,305.00 | |
Feb. 19, 2020 | EVP | 1,375 | $16.48 | Sell | $22,660.00 | |
Feb. 19, 2020 | CEO | 8,817 | $16.48 | Sell | $145,304.16 | |
Feb. 19, 2020 | Insider | 2,975 | $16.48 | Sell | $49,028.00 | |
Jan. 9, 2020 | Director | 2,056 | $20.00 | Sell | $41,120.00 | |
Jan. 9, 2020 | CEO | 10,000 | $19.19 | Sell | $191,900.00 | |
Dec. 27, 2019 | EVP | 5,000 | $20.00 | Sell | $100,000.00 | |
Dec. 27, 2019 | Director | 2,944 | $20.00 | Sell | $58,880.00 | |
Dec. 18, 2019 | Director | 12,121 | $17.18 | Sell | $208,238.78 | |
Dec. 9, 2019 | Director | 10,342 | $17.02 | Sell | $176,020.84 | |
Dec. 9, 2019 | CEO | 10,000 | $17.02 | Sell | $170,200.00 | |
Dec. 6, 2019 | EVP | 13,000 | $17.45 | Sell | $226,850.00 | |
Nov. 11, 2019 | Insider | 20,000 | $15.60 | Sell | $312,000.00 | |
Nov. 11, 2019 | CEO | 10,000 | $14.76 | Sell | $147,600.00 | |
Nov. 8, 2019 | CEO | 10,000 | $14.63 | Sell | $146,300.00 | |
Nov. 1, 2019 | CEO | 20,000 | $14.17 | Sell | $283,400.00 | |
Nov. 1, 2019 | Insider | 10,000 | $12.00 | Sell | $120,000.00 | |
Sept. 16, 2019 | CEO | 10,000 | $12.00 | Sell | $120,000.00 |
Insiders are both buying and selling Karyopharm Therapeutics Inc stock.
The insider traders at Karyopharm Therapeutics Inc are: Ltd Chione, Michael Kauffman, Sharon Shacham, Richard A Paulson, Christopher Brett Primiano, Mansoor Raza Mirza, Marcin Czernik, Michael Mason, Deepika Pakianathan, Jatin Shah, Stuart Poulton, Sohanya Roshan Cheng, Reshma Rangwala, Ran Frenkel, Garen G Bohlin, Stephen Mitchener, Michael Mano, Tanya Lewis, John Demaree, Justin A Renz, Ltd Plio, Paul Brannelly, Paulson Richard A., and Barry E Greene
The most active insider trader at Karyopharm Therapeutics Inc is Ltd Chione with 36 trades.
Ltd Chione has sold the most Karyopharm Therapeutics Inc stock with a total value of $91,689,798.39.
Deepika Pakianathan has bought the most Karyopharm Therapeutics Inc stock with a total value of $10,995,453.42.
The most recent insider trade for Karyopharm Therapeutics Inc was on Oct. 4, 2024.
The single biggest insider buy for Karyopharm Therapeutics Inc was from Deepika Pakianathan with a total value of $5,000,000.00 on Nov. 12, 2013.
The single biggest insider sell for Karyopharm Therapeutics Inc was from Ltd Plio with a total value of $17,770,000.00 on July 23, 2014.